title: Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival.
abstract: A correlation between expression of the glucose-regulated protein of 78 kDa (GRP78) in malignant melanoma tumors and poor patient survival is well established. In this study, in addition to demonstrating the expression of GRP78 in tumor tissue, we investigated the immune response against GRP78 in a group of patients with different progression stages of malignant melanoma. Furthermore, we analyzed the glycosylation status of GRP78 immunoglobulin (Ig) G autoantibodies at these stages and evaluated their capacities to affect the protein B-dependent protein kinase signaling pathway and unfolded protein response signaling mechanisms, all known to promote malignant melanoma cell proliferation and survival. We found that progression of disease correlates not only with enhanced expression of GRP78 in the tumor but also with an increase in GRP78 autoantibody serum titers in these patients. We also found that the glycosylation status of anti-GRP78 IgG changes as the disease progresses. The anti-GRP78 IgG is abnormally glycosylated in the Fc region and asymmetrically glycosylated in the Fab region. We demonstrate that hyperglycosylated anti-GRP78 IgGs stimulate cell proliferation through protein B-dependent protein kinase signaling pathways. They also mimic the effects of α2-macroglobulin on the upregulation of GRP78 and X-box binding protein 1, activating transcription factor 6 α, and serine/threonine-protein kinase/endoribonuclease precursor α as endoplasmic reticulum stress biomarkers and show no effect on expression or activation of caspases 3, 9, or 12. In conclusion, the anti-GRP78 IgG autoantibodies downregulate apoptosis and activate unfolded protein response mechanisms, which are essential to promote melanoma cell growth and survival.
authors: Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
authors: Maria A
authors: MA
authors: Selim
authors: James L
authors: JL
authors: Burchette
authors: Edith V
authors: EV
authors: Bowers
authors: Gustaaf G
authors: GG
authors: de Ridder
authors: Lihong
authors: L
authors: Mo
authors: Salvatore V
authors: SV
authors: Pizzo
authors: Mario
authors: M
authors: Gonzalez-Gronow
references: J Biol Chem. 2006 May 12;281(19):13694-13707
references: 16543232
references: Oncol Rep. 1998 Nov-Dec;5(6):1519-24
references: 9769398
references: Cancer Metastasis Rev. 2005 Jun;24(2):273-85
references: 15986137
references: Immunol Rev. 1998 Jun;163:77-87
references: 9700503
references: Protein Expr Purif. 2001 Jun;22(1):148-58
references: 11388813
references: Clin Cancer Res. 1997 Sep;3(9):1557-64
references: 9815843
references: Melanoma Res. 2011 Feb;21(1):35-43
references: 21164368
references: Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
references: 388439
references: Nature. 1970 Aug 15;227(5259):680-5
references: 5432063
references: Cancer Res. 2001 Nov 15;61(22):8322-30
references: 11719466
references: Hum Pathol. 2007 Oct;38(10):1547-52
references: 17640713
references: Int J Cancer. 2005 Mar 1;113(6):920-7
references: 15514946
references: Cancer Res. 2006 Dec 1;66(23):11424-31
references: 17145889
references: Annu Rev Immunol. 1988;6:535-54
references: 3289577
references: Nat Biotechnol. 2003 Jan;21(1):57-63
references: 12496764
references: Anticancer Res. 2008 Mar-Apr;28(2A):715-20
references: 18507012
references: Proc Natl Acad Sci U S A. 1981 Apr;78(4):2244-8
references: 7017728
references: Nat Rev Cancer. 2004 Dec;4(12):966-77
references: 15573118
references: J Biol Chem. 1988 Jan 15;263(2):728-34
references: 3335522
references: Anticancer Res. 2006 Nov-Dec;26(6B):4293-7
references: 17201147
references: Clin Chim Acta. 2006 Feb;364(1-2):308-15
references: 16182273
references: Lung Cancer. 2005 Jul;49(1):55-62
references: 15949590
references: J Hepatol. 2003 May;38(5):605-14
references: 12713871
references: Springer Semin Immunopathol. 1993;15(2-3):259-73
references: 7504841
references: Hum Pathol. 2004 Feb;35(2):217-23
references: 14991540
references: Anal Biochem. 1985 Oct;150(1):76-85
references: 3843705
references: J Immunol. 1989 May 1;142(9):3329-35
references: 2785141
references: Cancer Res. 2007 Oct 15;67(20):9809-16
references: 17942911
references: Histopathology. 2009 Mar;54(4):462-70
references: 19309398
references: Mol Immunol. 1986 Dec;23(12):1397-400
references: 3821742
references: Breast Cancer Res Treat. 2000 Jan;59(1):15-26
references: 10752676
references: Anticancer Res. 2004 Sep-Oct;24(5B):3135-9
references: 15510601
references: Gynecol Oncol. 2001 Apr;81(1):71-6
references: 11277653
references: Cancer Res. 2006 Aug 15;66(16):7849-53
references: 16912156